Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03794440 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma. |
| First Submitted : | January 3, 2019 |
| First Submitted that Met QC Criteria : | January 3, 2019 |
| First Posted : | January 7, 2019 |
| Last Update Submitted that Met QC Criteria : | January 21, 2021 |
| Last Update Posted : | January 22, 2021 |